WLFDY yields 67.73% · JNJ yields 2.13%● Live data
📍 WLFDY pulled ahead of the other in Year 1
Combined, WLFDY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WLFDY + JNJ for your $10,000?
Wolford Aktiengesellschaft produces and markets legwear, ready-to-wear garments, lingerie, beachwear, and accessories in Austria, Germany, France, the United Kingdom, Ireland, rest of Europe, North America, and Asia/Oceania. Its legwear products include pantyhose, tights, leggings, stay-ups, knee-highs, and socks; and lingerie comprises bras, briefs, bodies, garter belts, and slips. The company's ready-to-wear products include sweaters, dresses, skirts, and trousers; accessories comprise scarves and belts; and beachwear products include swimsuits and bikinis. It also offers bodysuits and close-fitting knitwear, such as tops and shirts. The company sells its products through boutiques, concession shop-in-shops, online business, factory outlets, department stores, specialist retail stores, and private label. As of December 31, 2021, it had 229 monobrand points of sales, which include 101 boutiques, 48 concession shop-in-shops, and 18 factory outlets owned by the company; 62 partners-operated boutiques; and approximately 2,500 other distribution partners. The company was founded in 1950 and is headquartered in Bregenz, Austria. Wolford Aktiengesellschaft is a subsidiary of Fosun Industrial Holdings Limited.
Full WLFDY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.